Kimberly-Clark (KMB) is close to selling its Kleenex and tissue businesses outside North America for approximately $3.5B, Lauren Thomas and Ben Dummett of The Wall Street Journal reports. This move is part of an attempt by the company to focus on more profitable areas, people familiar with the matter told the Journal. The company is set to sell the division to Suzano (SUZ) and a deal could be completed as soon as Thursday, the sources added.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KMB:
- M&A News: Kimberly-Clark Eyes $3.5B Global Tissue Sale amid Portfolio Overhaul
- Joint Corp. appoints Karrmann as Director
- Kimberly-Clark Transfers Stock Listing to Nasdaq
- Kimberly-Clark to transfer its U.S. stock exchange listing to Nasdaq
- Kimberly Clark’s Strategic Reorganization and Growth Potential Earns Buy Rating
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue